PMID- 30543909 OWN - NLM STAT- MEDLINE DCOM- 20200227 LR - 20200227 IS - 1878-5921 (Electronic) IS - 0895-4356 (Linking) VI - 107 DP - 2019 Mar TI - Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons. PG - 107-115 LID - S0895-4356(18)30361-5 [pii] LID - 10.1016/j.jclinepi.2018.12.005 [doi] AB - BACKGROUND AND OBJECTIVE: Despite plausible laboratory evidence about harms of endocrine-disrupting chemicals (EDCs), systematic reviews and meta-analyses of epidemiological studies do not consistently find such harms. The purpose of this article was to discuss why solid human evidence on EDCs was unlikely to be obtainable even though they are truely harmful to humans. RESULTS: Indeed, there are insurmountable methodological limitations in human studies. They include unpredictable net effects of diverse EDC mixtures, low reliability of exposure assessment, nonmonotonic dose-response relationships, nonexistence of an unexposed group, and complicated interactions with diet and obesity. The exposome is never free from these methodological issues. Therefore, the most persuasive evidence about human harms of EDCs may be increasing EDC-linked diseases at population levels, but traditional epidemiological studies of EDCs, especially short-lived and widely used EDCs, fail to provide consistent results. Nevertheless, human studies of EDCs with long half-lives, for example, persistent organic pollutants (POPs), are still worthwhile because there are fewer methodological issues. Also, they can play a role as surrogate markers of lipophilic chemical mixtures. Notably, although POPs are well-known EDCs, human findings on POPs cannot be attributed to common hormone-disrupting properties because the net effect of diverse EDC mixtures cannot be reliably predicted even with POPs. Homeostasis disruption through mitochondrial dysfunction may be more relevant to such effects. CONCLUSION: Logical inference should play a primary role in judging harms of EDCs in humans. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Lee, Duk-Hee AU - Lee DH AD - Department of Preventive Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea; Department of Biomedical Science, BK21 Plus KNU Biomedical Convergence Program, Kyungpook National University, Daegu, Republic of Korea. Electronic address: lee_dh@knu.ac.kr. FAU - Jacobs, David R Jr AU - Jacobs DR Jr AD - Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181210 PL - United States TA - J Clin Epidemiol JT - Journal of clinical epidemiology JID - 8801383 RN - 0 (Endocrine Disruptors) RN - 0 (Environmental Pollutants) SB - IM CIN - J Clin Epidemiol. 2019 Jul;111:124-126. PMID: 30905697 MH - Comorbidity MH - Endocrine Disruptors/*toxicity MH - Environmental Pollutants/*toxicity MH - Epidemiologic Methods MH - Half-Life MH - Homeostasis MH - Humans MH - Mitochondria/metabolism MH - Obesity/*epidemiology MH - Reproducibility of Results MH - Research Design OTO - NOTNLM OT - Chemical mixtures OT - EDCs OT - Epidemiology OT - Nonmonotonic dose-response relationship OT - Reliability EDAT- 2018/12/14 06:00 MHDA- 2020/02/28 06:00 CRDT- 2018/12/14 06:00 PHST- 2018/05/20 00:00 [received] PHST- 2018/09/27 00:00 [revised] PHST- 2018/12/05 00:00 [accepted] PHST- 2018/12/14 06:00 [pubmed] PHST- 2020/02/28 06:00 [medline] PHST- 2018/12/14 06:00 [entrez] AID - S0895-4356(18)30361-5 [pii] AID - 10.1016/j.jclinepi.2018.12.005 [doi] PST - ppublish SO - J Clin Epidemiol. 2019 Mar;107:107-115. doi: 10.1016/j.jclinepi.2018.12.005. Epub 2018 Dec 10.